GRM5 and ischemia: On the other hand, selective antagonists of mGlu1 and mGlu5 can be neuroprotective, both in organotypic cultures subjected to 3-nitropropionic acid (3-NP) insult in vitro, and in a middle cerebral artery-occlusion model of ischemia in vivo [32].